Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

I Bièche

Showing results (61-70 of 91) with videos related to

Pageof 10
Sort By:
British Journal of Cancer|March 6, 2015
ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levelsS Rondeau, S Vacher, L De Koning, et al.
Cancer Research|March 23, 2000
Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancerR Lidereau, F Eisinger, M H Champème, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2015
Designs of preoperative biomarkers trials in oncology: a systematic review of the literatureM Marous, I Bièche, X Paoletti, et al.
Cancer Letters|November 2, 2001
ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinomaI Bièche, P Onody, F Lerebours, et al.
Cancer Research|February 1, 1997
Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cellsD Bellet, V Lazar, I Bièche, et al.
Annales De Biologie Clinique|January 9, 2004
[RT-PCR in clinical diagnosis]H Cavé, C Acquaviva, I Bièche, et al.
The Journal of Pathology|October 10, 2001
hTERT expression in sporadic renal cell carcinomasV Paradis, I Bièche, D Dargère, et al.
Gut|September 16, 2005
Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the diseaseV Paradis, I Bièche, D Dargère, et al.
Oncogene|March 3, 1998
Low frequency of TSG101/CC2 gene alterations in invasive human breast cancersQ Wang, K Driouch, S Courtois, et al.
Journal of Molecular Endocrinology|October 3, 2007
Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifenS Tozlu-Kara, V Roux, C Andrieu, et al.
Pageof 10

Showing results (61-70 of 91) with videos related to

Sort By:
Pageof 10
British Journal of Cancer|March 6, 2015
ATM has a major role in the double-strand break repair pathway dysregulation in sporadic breast carcinomas and is an independent prognostic marker at both mRNA and protein levelsS Rondeau, S Vacher, L De Koning, et al.
Cancer Research|March 23, 2000
Major improvement in the efficacy of BRCA1 mutation screening using morphoclinical features of breast cancerR Lidereau, F Eisinger, M H Champème, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|September 16, 2015
Designs of preoperative biomarkers trials in oncology: a systematic review of the literatureM Marous, I Bièche, X Paoletti, et al.
Cancer Letters|November 2, 2001
ERBB2 status and benefit from adjuvant tamoxifen in ERalpha-positive postmenopausal breast carcinomaI Bièche, P Onody, F Lerebours, et al.
Cancer Research|February 1, 1997
Malignant transformation of nontrophoblastic cells is associated with the expression of chorionic gonadotropin beta genes normally transcribed in trophoblastic cellsD Bellet, V Lazar, I Bièche, et al.
Annales De Biologie Clinique|January 9, 2004
[RT-PCR in clinical diagnosis]H Cavé, C Acquaviva, I Bièche, et al.
The Journal of Pathology|October 10, 2001
hTERT expression in sporadic renal cell carcinomasV Paradis, I Bièche, D Dargère, et al.
Gut|September 16, 2005
Quantitative gene expression in Budd-Chiari syndrome: a molecular approach to the pathogenesis of the diseaseV Paradis, I Bièche, D Dargère, et al.
Oncogene|March 3, 1998
Low frequency of TSG101/CC2 gene alterations in invasive human breast cancersQ Wang, K Driouch, S Courtois, et al.
Journal of Molecular Endocrinology|October 3, 2007
Oligonucleotide microarray analysis of estrogen receptor alpha-positive postmenopausal breast carcinomas: identification of HRPAP20 and TIMELESS as outstanding candidate markers to predict the response to tamoxifenS Tozlu-Kara, V Roux, C Andrieu, et al.
Pageof 10